Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000967758 | SCV001115176 | likely benign | not provided | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002548323 | SCV003722890 | uncertain significance | Inborn genetic diseases | 2021-08-23 | criteria provided, single submitter | clinical testing | The c.4772G>A (p.R1591K) alteration is located in exon 33 (coding exon 32) of the PCDH15 gene. This alteration results from a G to A substitution at nucleotide position 4772, causing the arginine (R) at amino acid position 1591 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000967758 | SCV005220760 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001277671 | SCV001464635 | likely benign | Usher syndrome type 1F | 2020-09-23 | no assertion criteria provided | clinical testing |